The collaboration builds on research from Harbour, Utrecht and Erasmus, which discovered a coronavirus-neutralizing antibody known as 47D11. Under the terms of the deal, AbbVie will support preclinical activities of the three parties and prepare for later-stage clinical development work, with an option to exclusively license the antibody, the statement says. Financial terms were not disclosed.
Chef CEO says he’ll continue to work with ICE in spite of protests
2ff7e9595c
Comentários